The FDA has granted Fast Track designation to Cellphire Therapeutics' CLPH-511, a frozen activated platelet product designed to treat acute hemorrhage when conventional platelets are unavailable or in short supply.
United Health Products has made significant progress in its FDA IDE application process for CelluSTAT, resolving key preclinical testing protocol concerns through recent discussions with the FDA.
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.